Novavax (NVAX) IV at 133 into developing Covid-19 vaccine
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) 30-day option implied volatility is at 133; compared to its 52-week range of 85 to 312 into developing Covid-19 vaccine.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Autodesk (ADSK) call put ratio 1.4 calls to 1 puts into quarter results
- Marvell Technology (MRVL) call put ratio 1.6 calls to 1 put into quarter results
- SentinelOne, Inc. (S) call put ratio 9.1 calls to 1 put with a focus on August 25 weekly calls into tquarter results
Create E-mail Alert Related Categories
OptionsRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
